Surya Medisales Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 17-11-2024
- Paid Up Capital ₹ 6.04 M
as on 17-11-2024
- Company Age 24 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.39 Cr
as on 17-11-2024
- Satisfied Charges ₹ 6.04 Cr
as on 17-11-2024
- Revenue -0.93%
(FY 2023)
- Profit -39.91%
(FY 2023)
- Ebitda -19.71%
(FY 2023)
- Net Worth 8.51%
(FY 2023)
- Total Assets 8.31%
(FY 2023)
About Surya Medisales
The Corporate was formerly known as Rajasthan Laser Eye Centre Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.04 M.
The company currently has active open charges totaling ₹5.39 Cr. The company has closed loans amounting to ₹6.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anjani Bawri, Saroj Bawri, and Amit Bawari serve as directors at the Company.
- CIN/LLPIN
U58110RJ2000PTC016749
- Company No.
016749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2000
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Surya Medisales Private Limited offer?
Surya Medisales Private Limited offers a wide range of products and services, including Medical Imaging Machine & Accessories, Contrast Media.
Who are the key members and board of directors at Surya Medisales?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjani Bawri  | Director | 24-Nov-2000 | Current |
| Saroj Bawri | Director | 01-Dec-2004 | Current |
| Amit Bawari | Director | 04-Dec-2008 | Current |
Financial Performance of Surya Medisales.
Surya Medisales Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.93% decrease. The company also saw a substantial fall in profitability, with a 39.91% decrease in profit. The company's net worth moved up by a moderate rise of 8.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Surya Medisales?
In 2023, Surya Medisales had a promoter holding of 90.53% and a public holding of 9.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 27 Sep 2023 | ₹3.40 M | Open |
Hdfc Bank Limited Creation Date: 14 Oct 2022 | ₹2.01 M | Open |
Axis Bank Limited Creation Date: 05 Jan 2022 | ₹3.99 M | Open |
How Many Employees Work at Surya Medisales?
Unlock and access historical data on people associated with Surya Medisales, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Surya Medisales, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Surya Medisales's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
